首页> 外文期刊>The Open Colorectal Cancer Journal >RON - The Con in Colorectal Carcinoma
【24h】

RON - The Con in Colorectal Carcinoma

机译:RON-大肠癌中的骗局

获取原文
       

摘要

The recepteur d’origine nantais (RON) is a member of MET family of receptor tyrosine kinase (RTKs), an overexpression of which has been observed in several cancers. The expression of RON gene is required during embryonic development and also plays critical roles in regulating macrophage inflammatory response. In CRC, the overexpression of moderate RON activity contributes to their oncogenic potential by regulating several key processes such as proliferation, motility and resistance to apoptosis. Interestingly, an aberrant RON expression is often associated with the generation of several splice variants with unique transforming activities. The targeting of RON signaling pathway by the use of mono-clonal antibodies and small-molecule inhibitors has shown promising therapeutic results in animal models. The present ar-ticle aims at summarizing the current understanding of RON kinase in CRC.
机译:d'origine nantais受体(RON)是MET受体酪氨酸激酶(RTKs)家族的成员,在几种癌症中均发现其过度表达。 RON基因的表达在胚胎发育过程中是必需的,并且在调节巨噬细胞炎症反应中也起着关键作用。在CRC中,中等RON活性的过表达通过调节几个关键过程(例如增殖,运动性和对凋亡的抵抗力)有助于其致癌潜力。有趣的是,异常的RON表达通常与具有独特转化活性的几种剪接变体的产生有关。在动物模型中,通过使用单克隆抗体和小分子抑制剂靶向RON信号通路已显示出令人鼓舞的治疗效果。本发明旨在总结对CRC中RON激酶的当前理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号